Article Details

Sutro Biopharma Reports Full Year 2024 Financial Results and Business Highlights

Retrieved on: 2025-03-13 20:12:21

Tags for this article:

Click the tags to see associated articles and topics

Sutro Biopharma Reports Full Year 2024 Financial Results and Business Highlights. View article details on hiswai:

Excerpt

The year 2024 includes non-cash expenses for stock-based compensation of $24.7 million and depreciation and amortization of $7.2 million, as compared ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo